Cover Image
市場調查報告書

歐洲的子宮栓塞術設備市場分析

European Market Report for Uterine Fibroid Embolization Devices

出版商 iData Research Inc. 商品編碼 371089
出版日期 內容資訊 英文 81 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的子宮栓塞術設備市場分析 European Market Report for Uterine Fibroid Embolization Devices
出版日期: 2016年09月01日 內容資訊: 英文 81 Pages
簡介

本報告提供歐洲各國子宮栓塞術 (UFE) 設備的市場相關分析,提供您技術·產品概要,及整體市場規模的實際成果值·預測值,各產品詳細趨勢,主要的推動及阻礙市場要素,主要企業的市場佔有率,各國市場的市場結構等調查評估。

摘要整理

歐洲的婦產科用醫療設備的市場:概要

競爭分析

市場趨勢

市場發展

治療數量

分析對象市場

主要報告的更新情形

過去的版本

調查手法

  • 調查範圍
  • IDATA的9等級分析方法

各國市場簡介

  • 簡介
    • 人口
    • 平均年齡
    • 每人GDP
    • 價格指數
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

子宮栓塞術設備的市場

  • 簡介
    • 微粒子 (Microspheres)
    • PVA (聚乙烯醇) 粒子
    • 藥物釋放型粒子
  • 市場概要
  • 市場分析與預測
    • 子宮肌瘤栓塞治療
      • 微粒子
      • PVA粒子
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 各企業市場佔有率分析

簡稱一覽

目錄
Product Code: iDATA_ EUGYN16_MC_UFE

The UFE market has decreased over the past couple of years as there has been a reduction of active marketing. Moreover, UFE must compete with a wide array of procedures available to treat heavy bleeding due to uterine fibroids. These other treatments and procedures include hysterectomy, pharmacological alternatives, global endometrial ablation, endometrial resection and other minimally invasive surgical procedures. For more price-sensitive countries, such as France, Spain, Italy and Portugal, alternative treatments present significant competition as patients and physicians look for inexpensive methods for the management or treatment of uterine fibroids. Moreover, because of the economic situation, many women are delaying surgical treatments.

Uterine fibroid embolization (UFE), also known as uterine artery embolization (UAE) is a radiology treatment for fibroids. Fibroids, also known as myomas, are masses of muscle tissue and fiber located on the wall of the uterus that can cause heavy bleeding and pain. Fibroids depend on the uterine arteries for nourishment, and they take significant blood supply from these vessels. UFE restricts blood flow to fibroids, causing them to shrink significantly. This procedure does not involve general anesthesia and is appropriate for women who want an alternative to a myomectomy, also known as fibroidectomy. It is a much less invasive way to treat fibroids than a hysterectomy, has a much shorter recovery time and leaves almost no scarring. The effects of UFE on fertility are being researched; some results suggest that fertility after UFE is comparable to fertility after myomectomy.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • 1.2.1. Step 1: Project Initiation & Team Selection
    • 1.2.2. Step 2: Prepare Data Systems and Perform Secondary Research
    • 1.2.3. Step 3: Preparation for Interviews & Questionnaire Design
    • 1.2.4. Step 4: Performing Primary Research
    • 1.2.5. Step 5: Research Analysis: Establishing Baseline Estimates
    • 1.2.6. Step 6: Market Forecast and Analysis
    • 1.2.7. Step 7: Identify Strategic Opportunities
    • 1.2.8. Step 8: Final Review and Market Release
    • 1.2.9. Step 9: Customer Feedback and Market Monitoring

COUNTRY PROFILES

  • 2.1. INTRODUCTION
    • 2.1.1.1. Population
    • 2.1.1.2. Median Age
    • 2.1.1.3. GDP Per Capita
    • 2.1.1.4. Price Index
  • 2.2. GERMANY
  • 2.3. FRANCE
  • 2.4. UNITED KINGDOM
  • 2.5. ITALY
  • 2.6. SPAIN
  • 2.7. BENELUX
  • 2.8. SCANDINAVIA
  • 2.9. AUSTRIA
  • 2.10. SWITZERLAND
  • 2.11. PORTUGAL

UTERINE FIBROID EMBOLIZATION DEVICE MARKET

  • 3.1. INTRODUCTION
    • 3.1.1. Microspheres
    • 3.1.2. Polyvinyl Alcohol Particles
    • 3.1.3. Drug-eluting Particles
  • 3.2. MARKET OVERVIEW
  • 3.3. MARKET ANALYSIS AND FORECAST
    • 3.3.1. Uterine Fibroid Embolization Procedures
      • 3.3.1.1. Microspheres Market
      • 3.3.1.2. PVA Particles Market
  • 3.4. DRIVERS AND LIMITERS
    • 3.4.1. Market Drivers
    • 3.4.2. Market Limiters
  • 3.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Back to Top